
Venus Concept VERO
Quartalsbericht 2025-Q3
hinzugefügt 16.05.2026
Venus Concept DSO 2011-2026 | VERO
DSO Jährlich Venus Concept
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 181 | 221 | 228 | 243 | 264 | 195 | 109 | 66.2 | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 264 | 66.2 | 188 |
DSO Vierteljährlich Venus Concept
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 161 | 139 | 167 | - | 185 | 185 | 191 | - | 231 | 224 | 234 | - | 274 | 237 | 248 | - | 252 | 239 | 277 | - | 310 | 377 | 501 | - | 311 | 292 | 293 | 518 | 124 | 109 | 95.1 | 60.2 | 84.4 | 60.9 | 52.9 | 43.7 | 30.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 518 | 30.8 | 210 |
DSO anderer Aktien in der Medizinische Geräte
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | ||
|
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
50.8 | - | - | $ 3.31 B | ||
|
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M | ||
|
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | ||
|
ClearPoint Neuro
CLPT
|
55.6 | $ 11.2 | 0.27 % | $ 317 M | ||
|
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
43.1 | $ 8.24 | 0.24 % | $ 1.24 B | ||
|
Aziyo Biologics
AZYO
|
59.5 | - | 1.37 % | $ 20.5 M | ||
|
EDAP TMS S.A.
EDAP
|
104 | $ 4.25 | -1.62 % | $ 159 M | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | ||
|
LENSAR
LNSR
|
38.9 | $ 5.88 | 1.38 % | $ 70.3 M | ||
|
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
2.12 | $ 2.31 | 6.94 % | $ 50.9 M | ||
|
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | ||
|
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | ||
|
Cytosorbents Corporation
CTSO
|
73.2 | $ 0.47 | -0.57 % | $ 29.2 M | ||
|
MiMedx Group
MDXG
|
57.3 | $ 3.79 | 4.12 % | $ 560 M | ||
|
OrthoPediatrics Corp.
KIDS
|
74.3 | $ 18.5 | 1.48 % | $ 434 M | ||
|
LivaNova PLC
LIVN
|
53.8 | $ 73.71 | 1.08 % | $ 4.02 B | ||
|
Delcath Systems
DCTH
|
48.5 | $ 11.23 | 3.5 % | $ 402 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
120 | - | - | $ 111 M | ||
|
IRIDEX Corporation
IRIX
|
26.4 | $ 1.0 | -4.76 % | $ 16.9 M | ||
|
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
70.8 | - | - | $ 10.2 M | ||
|
Pulmonx Corporation
LUNG
|
50.8 | $ 1.54 | 14.93 % | $ 62.7 M | ||
|
Electromed
ELMD
|
137 | $ 37.74 | -1.64 % | $ 319 M | ||
|
Myomo
MYO
|
35.3 | $ 0.91 | 4.17 % | $ 38.1 M | ||
|
Butterfly Network
BFLY
|
88.9 | $ 4.39 | 6.94 % | $ 1.08 B | ||
|
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | ||
|
Orthofix Medical
OFIX
|
60 | $ 12.15 | 0.5 % | $ 481 M | ||
|
Sintx Technologies
SINT
|
67 | $ 2.21 | 0.45 % | $ 6.13 M | ||
|
GBS
GBS
|
61.2 | - | -0.57 % | $ 7.12 M | ||
|
Profound Medical Corp.
PROF
|
161 | $ 6.92 | 2.82 % | $ 209 M | ||
|
Globus Medical
GMED
|
76.8 | $ 84.03 | 5.13 % | $ 11.4 B | ||
|
Insulet Corporation
PODD
|
15.2 | $ 156.59 | 1.28 % | $ 11 B | ||
|
CONMED Corporation
CNMD
|
64.5 | $ 37.01 | 2.29 % | $ 1.15 B | ||
|
Inspire Medical Systems
INSP
|
42.6 | $ 44.14 | 3.79 % | $ 1.3 B | ||
|
TransMedics Group
TMDX
|
54.9 | $ 68.0 | 2.83 % | $ 2.31 B | ||
|
Integer Holdings Corporation
ITGR
|
58.2 | $ 91.49 | 1.16 % | $ 3.18 B | ||
|
Invacare Corporation
IVC
|
206 | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
38.2 | $ 82.97 | 0.99 % | $ 48.5 B |